Cite

HARVARD Citation

    Ballal, S. et al. (2021). 225Ac‐PSMA‐617‐targeted alpha therapy for the treatment of metastatic castration‐resistant prostate cancer: A systematic review and meta‐analysis. Prostate. 81 (9), pp. 580-591. [Online]. 
  
Back to record